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1. Introduction
   Hyperkalaemia is a common feature of acute kidney 
injury of any cause. Percutaneous nephrostomy (PCN) under 
local anaesthesia or retrograde ureteric stenting under 
general anaesthesia are effective treatments to relieve 
renal impairment due to ureteric obstruction[1]. Pre-
procedural hyperkalaemia is often a cause of concern for 
anaesthetic and radiological staff due to the associated risk 
of dysrhythmia and sudden death. Decompression of the 
ureteric obstruction either by PCN or retrograde ureteric 
stent usually improves renal function or hyperkalaemia with 
a low morbidity[2,3]. Retrograde ureteric stent insertion in 
patients with malignant ureteric obstruction carries a higher 
failure rate compared to PCN; furthermore the majority 
of patients will need a general anaesthetic which may be 
challenging when complicated with hyperkalaemia[4]. 
   There are no specific guidelines on management of 
patients with hyperkalaemia due to ureteric obstruction. 
Wide variation in management exists in some patients 
undergoing dialysis, having infusion of dextrose/insulin, 
inhaling salbutamol or terbutaline and receiving oral/
rectal calcium resonium, and most patients having a 
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Results: A total of 61 patients (40 males and 21 females) with mean age of 69.7 years (ranged 35 
to 94 years) underwent 69 procedures. Prior to the nephrostomy, the serum potassium was mildly 
elevated in 42 cases, moderately elevated in 17 cases and severely elevated in 10 cases. The 
overall mean level of potassium before intervention was 6.1 mmol/L (range: 5.1 mmol/L-9.3 mmol/
L). Forty (58%) had nephrostomy without prior medical treatment of the hyperkalaemia. The mean 
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combination of the above. Once the potassium is normalised, 
decompression of the ureter is achieved by either PCN or 
ureteric stenting. A handful of case reports, however, have 
suggested that early nephrostomy can help normalise the 
renal function and correct the potassium. Furthermore, 
no added morbidity has been reported following early 
nephrostomy. Whilst, as these case reports suggested, 
there are no large case series reported in the literature to 
verify the encouraging outcome. We hypothesised that an 
early nephrostomy in this group of patients without prior 
additional medical correction is effective without added 
morbidity. In order to test this hypothesis, we analysed 
our results with specific aims: 1. to assess the outcome of 
early nephrostomy in patients with ureteric obstruction, 
in particular the morbidity and outcome in terms of renal 
function and correction of hyperkalaemia; 2. to compare 
the outcomes of patients with and without medical 
treatment prior to hyperkalaemia. In some cases, medical 
management was commenced to prevent further increase in 
serum potassium whilst waiting nephrostomy and in others 
because intervention in a hyperkalaemic state was clinically 
considered hazardous in an unwell patient and drainage was 
delayed to allow for correction. 
2. Materials and methods 
   We investigated the outcomes of patients who underwent 
nephrostomy for hyperkalaemia with renal failure 
secondary to ureteric obstruction between January 2003 
and December 2008 at a single centre. Hyperkalaemia 
was defined as serum potassium greater than 5.0 mmol/
L and graded as mild (5.0 mmol/L-6.0 mmol/L), moderate 
(6.1 mmol/L-7.0 mmol/L) or severe (>7.1 mmol/L). Data 
was extracted from the radiology information system, 
biochemistry database, medical, interventional radiology 
and nursing notes and entered into a pre-designed data 
extraction sheets. Patients with no records available were 
excluded from the study. An experienced radiologist (AT) 
or registrar under supervision performed all procedures. 
Following parameters were recorded for each patient: 
age, sex, clinical presentation, presence of concurrent 
disease, creatinine, potassium, haemoglobin concentration, 
time interval in doing the nephrostomy since their first 
presentation to the hospital, any pre-nephrostomy medical 
correction of hyperkalaemia and complications. The success 
of the procedure was defined as resolution of hyperkalaemia 
and improvement in renal function. 
3. Results
   During our study period, a total of 61 patients, 40 males 
and 21 female, with mean age of 69.7 years (range 35 to 94 
years) underwent 69 procedures (Figures 1-3). All patients 
had hyperkalaemia and hydronephrosis due to ureteric 
obstruction. Pre-nephrostomy hydronephrosis was unilateral 
in 37 cases, bilateral in 27 cases, with one transplant kidney. 
In four patients the biochemistry failed to improve after 
unilateral nephrostomy and a subsequent contralateral 
nephrostomy was necessary. 
   The underlying cause was malignant ureteric obstruction 
in 46 patients, obstruction from ureteric calculi in 8 
patients, pyonephrosis in 4 patients and obstruction from a 
combination of retroperitoneal fibrosis and/or inflammatory 
aortic aneurysm in the remaining three patients. Prior to the 
nephrostomy, the serum potassium was mildly elevated in 42 
cases, moderately elevated in 17 cases and severely elevated 
in 10 cases. The overall mean potassium before intervention 
was 6.1 mmol/L (range: 5.1 mmol/L-9.3 mmol/L) (Table 1). 
   Twenty-nine (42%) had medical treatment of the 
hyperkalaemia prior to nephrostomy. This was to prevent 
further increase in serum potassium whilst waiting for a 
nephrostomy because intervention in a hyperkalaemic 
state was considered hazardous and drainage was delayed 
to allow correction (Figures 1a and 1b). Of these 29 cases, 
the mean potassium level was reduced from 6.7 mmol/L 
(range 5.4 mmol/L-9.3 mmol/L) before medical treatment to 
5.8 mmol/L (4.0 mmol/L-7.4mmol/L) with a mean reduction 
of 0.9 mmol/L (range: 0.8 mmol/L-4.2 mmol/L) (Figure 3). 
Table 1
Pre and post nephrostomy potassium, creatinine and WBC count.
Parameters n Minimum Maximum Mean SD
Age (years) 69 35.0     94.0   69.7  13.1
Pre nephrostomy K (all) (mmol/L) 69   5.1       9.3     6.1    0.8
Pre-nephrostomy K, no MM (mmol/L) 40   5.1       7.5     5.6    0.5
Pre-nephrostomy K, pre MM (mmol/L) 29   5.4       9.3     6.7    0.8
Pre-nephrostomy K, post MM (mmol/L) 29   4.0       7.4     5.8
Pre-nephrostomy creatinine 69 62.0 1602.0 553.5 320.0
Pre-nephrostomy WBC 63   3.1     26.9   10.7     5.3
Post-nephrostomy K (next day) 69   3.4       7.1     4.8     0.7
Post-nephrostomy creatinine 68 68.0 1002.0 223.4 175.6
MM: Medical management; K: Potassium; WBC: White blood cell count.
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A combination of medical measures was used for most 
patients, with insulin dextrose being the commonest (n=20), 
oral calcium resonium (n=17) and haemodialysis (n=8) in 
others. Mean delay from presentation to nephrostomy was 
1.9 d. 
Outcome of PCN done for all patients
Biochemical response, n=47 
Unilateral, n=25
Bilateral, n=22
Total biochemial response, n=51 
Unilateral, n=26 
Bilateral, n=25
No Biochemical response, n=14 
Unilateral, n=9 
Bilateral, n=5
No response, n=18 
Unilateral, n=13 
Bilateral, n=5
61 patients, 69 procedures
Further procedure, n=4
Figure 2. Algorithm showing outcomes of all patients undergoing 
PCN.
   Forty (58%) had nephrostomy without prior medical treatment 
of the hyperkalaemia. The mean serum potassium in these 
patients was 5.6 mmol/L (range 5.1 mmol/L-7.5 mmol/L). 
Twenty-four of these procedures (60%) were done within 24 h 
of presentation. The mean time delay from presentation to 
nephrostomy was 1.4 d (range: 0-3 d). 
   Five patients (7%) had complications from PCN including 
atrial fibrillation (AF) in 3 patients and transient pyrexia 
in 2 patients, both of which settled with antibiotics. Of 
the three patients with AF, 2 had no medical treatment 
prior to nephrostomy. Whilst AF in two patients resolved 
spontaneously the third needed temporary treatment with 
verapamil. There were no other hyperkalaemia or procedure 
related complications. 
   Bilateral PCN was done in 27 cases, resulting in 
normalisation of the serum biochemistry in 22 (81%) cases. 
In the remaining 5 cases there was no improvement in the 
serum potassium or creatinine. Unilateral nephrostomy 
was performed initially in 37 cases, and one transplant 
kidney. In 25 (66%) cases there was normalisation of the 
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Figure 1. ECG from patient with serum potassium of 9.3 mmol/L (a) and more normal ECG from the same patient after nephrostomy and 
normalisation of the serum potassium (b). 
In Figure 1a, the P waves are small, PR interval is prolonged; the QRS complex is widened at 154 ms; the T waves are taller than the R wave; 
the ST segment is sloping and the QT interval is long.
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serum potassium and creatinine, but with no significant 
improvement in other 13 cases. Of the latter, 2 cases needed 
the contralateral side drained and two other cases needed 
a repeat procedure due to nephrostomy catheter extrusion 
(Figure 1).
4. Discussion
4.1. Principle findings
   The safest and most effective treatment of hyperkalaemia 
due to obstructive uropathy is early relief of obstruction 
(drainage of both kidneys where there is bilateral 
hydronephrosis). From the data, there is no obvious 
relationship between the severity of hyperkalaemia, the 
response to nephrostomy and the time taken for potassium 
and creatinine to normalise after nephrostomy. In our study, 
initial PCN was performed within 24 h of presentation in 42 
(62%) of patients and was successful in normalising serum 
potassium and creatinine in 50 (72%) and 25 (36%) of the 
patients within 48 h. The minor complication rate was 7%, 
with AF, pyrexia and confusion more likely in patients with 
stone disease and leucocytosis, but was not associated with 
severity of hyperkalaemia. The complications in our study 
were well within acceptable levels as published by the 
American College of Radiologists (4% haemorrhage and 10% 
septicaemia/ septic shock). 
4.2. Limitations of the study
   This study is limited by small size and retrospective data 
collection. However, the authors believe that there is an 
important message for clinicians dealing with hyperkalaemia 
due to obstructive uropathy and for radiologists providing 
this service. There is a selection bias in patients undergoing 
medical management prior to nephrostomy versus 
nephrostomy as the first line treatment. This was because 
no prior data existed on the safety of nephrostomy on 
hyperkalaemic patients, and for clinically unwell patients or 
where delay in arranging nephrostomy was anticipated, we 
wanted to correct the potassium level prior to nephrostomy.  
 
4.3. Meaning of the study (possible mechanism and 
implications for future policy and practices)
   The serum potassium and creatinine returned to normal 
post drainage after a mean of 1.6 d and 3.3 d respectively in 
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Figure 3. Pre- and post-nephrostomy potassium for patients with and without medical management.
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50 patients in our study. Early nephrostomy is recommended 
for hyperkalaemia due to obstructive uropathy. There appears 
to be no advantage from reducing the serum potassium 
by medical means prior to intervention unless drainage is 
delayed. The risk of dying due to the arrythmogenic effect 
of hyperkalaemia during such a procedure is unclear but 
probably low with no fatalities reported in the literature. The 
urgency of the intervention is usually based on factors such 
as sepsis, pain, hyperkalaemia and the need for preservation 
of renal function especially in a solitary kidney. A large 
study of hospital in-patients confirmed the association of 
hyperkalaemia and increased mortality[5]. However there 
appeared to be a stronger association with the rate of change 
of serum potassium rather than the peak value. Levels of 10 
mmol/L appear compatible with survival[6].
   Identification of patients most at risk is difficult. The 
electrocardiographic changes of hyperkalaemia are 
unreliable especially in patients with chronic renal 
impairment partly due to associated serum calcium flux and 
partly due to poor observer sensitivity[5-9]. There are some 
evidences that other elevated metabolites in renal failure 
may be just as likely as potassium to cause cardiac or non-
cardiac morbidity[10]. Dialysis and other medical measures to 
decrease the serum potassium may be reassuring if drainage 
is not immediately available. However, dialysis requires the 
insertion of a central venous catheter and results in rapid 
electrolyte changes, both of which are potentially hazardous. 
The risk of cardiac arrhythmia and arrest for end stage renal 
patients are reported to be higher for dialysed than for non-
dialysed patients although this effect may not be significant 
in these unmatched groups[11,12].
   Radiologists performing nephrostomies on patients 
with hyperkalaemia may be reassured by the absence of 
published cardiac complications. The rationale for prior 
medical treatment appears weak and this study found no 
reason to delay nephrostomy. However, this implies access 
to imaging and interventional expertise, which is by no 
means universal for UK hospital in-patients in spite of 
recent recommendations[13].
   Our experience suggests that PCN need not be delayed for 
medical attempts to correct potassium unless the patient 
is haemodynamically compromised or there is a delay in 
arranging the nephrostomy. Early drainage of obstructive 
uropathy by PCN is an effective strategy to correct associated 
hyperkalaemia and restore renal function. PCN as the initial 
management for hyperkalaemia from ureteric obstruction 
is a safe procedure with acceptable complication rates. A 
careful attention to the agreed protocols/ algorithms, pre-
procedure antibiotic regimens, patient optimisation and a 
dedicated uro-radiology unit is essential to achieve optimal 
results.
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